1. Home
  2. CPB vs TVTX Comparison

CPB vs TVTX Comparison

Compare CPB & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Campbell Soup Company

CPB

Campbell Soup Company

N/A

Current Price

$19.34

Market Cap

5.8B

ML Signal

N/A

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

N/A

Current Price

$52.13

Market Cap

5.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CPB
TVTX
Founded
1869
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
5.3B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
CPB
TVTX
Price
$19.34
$52.13
Analyst Decision
Hold
Strong Buy
Analyst Count
20
15
Target Price
$20.79
★ $75.21
AVG Volume (30 Days)
★ 7.1M
1.6M
Earning Date
09-03-2026
10-29-2026
Dividend Yield
★ 5.16%
N/A
EPS Growth
N/A
★ 92.89
EPS
★ 1.31
N/A
Revenue
★ $9,744,000,000.00
N/A
Revenue This Year
N/A
$47.65
Revenue Next Year
N/A
$49.39
P/E Ratio
$14.79
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$18.60
$22.59
52 Week High
$32.04
$68.73

Technical Indicators

Market Signals
Indicator
CPB
TVTX
Relative Strength Index (RSI) 37.63 27.37
Support Level N/A $41.75
Resistance Level $21.31 $59.93
Average True Range (ATR) 0.56 2.36
MACD 0.00 -0.93
Stochastic Oscillator 38.78 5.91

Price Performance

Historical Comparison
CPB
TVTX

About CPB Campbell Soup Company

Over the past 150-plus years, Campbell's has evolved into a leading domestic packaged food manufacturer, with a portfolio that extends beyond its iconic red-and-white labeled canned soup. In fiscal 2026 (July year-end), meals and beverages accounted for 61% of its revenue, while snacks accounted for 39%. Beyond its namesake, its brands include Pepperidge Farm, Goldfish, Snyder's of Hanover, Swanson, Pacific Foods, Prego, Pace, V8, and, most recently, Rao's (a deal that closed in 2024). Around 90% of its revenue results from the US and the remainder from Canada and Latin America.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: